The document discusses monographs of herbal drugs from the Siddha and Unani pharmacopoeias. It provides an overview of the Unani pharmacopoeia of India and its monograph format, including sections on nomenclature, description, tests, and specifications. An example of a Unani monograph is given for Habb-e-Mudir. The Siddha pharmacopoeia of India and its monograph format are also reviewed, along with an example Siddha monograph for Amukkaru. References are provided at the end.
Regulatory requirement for setting herbal drug industryRAGHAV DOGRA
The World Health Organization (WHO) estimates that 80 percent of the population of some Asian and African countries presently use herbal medicine for some aspect of primary health care.Pharmaceuticals are prohibitively expensive for most of the world's population, half of whom lived on less than $2 U.S. per day in 2002. In comparison, herbal medicines can be grown from seed or gathered from nature for little or no cost
patent (/ˈpætənt/ or /ˈpeɪtənt/) is a set of exclusive rights granted by a sovereign state to an inventor or assignee for a limited period of time in exchange for detailed public disclosure of an invention. An invention is a solution to a specific technological problem and is a product or a process. Patents are a form of intellectual property.
In this slide contains Introductionnof Indian pharmacopeia, ayurvedic, unani pharmacopeia and monographs of herbal drugs.
Presented by: P.SUDHEER KUMAR (Department of pharmaceutical analysis ).RIPER, anantapur
In this slide contains Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American Herbal Pharmacopoeia.
Presented by: M.SUDHEESHNA (Department of pharmaceutical analysis ).RIPER, anantapur
Adulteration is the debasement of Genuine materials3.
It may be deliberated or accidentally done.
In crude drugs, this practice includes the substitution of the original crude drug, fully or partially with sub-stranded substances.
Sub-stranded substances include- Inferiority and spoilage.
Inferiority- Natural sub-stranded condition whose natural constituent is below the minimum standard.
Spoilage- sub-stranded condition produced by microbial or pest infestation.
Regulatory requirement for setting herbal drug industryRAGHAV DOGRA
The World Health Organization (WHO) estimates that 80 percent of the population of some Asian and African countries presently use herbal medicine for some aspect of primary health care.Pharmaceuticals are prohibitively expensive for most of the world's population, half of whom lived on less than $2 U.S. per day in 2002. In comparison, herbal medicines can be grown from seed or gathered from nature for little or no cost
patent (/ˈpætənt/ or /ˈpeɪtənt/) is a set of exclusive rights granted by a sovereign state to an inventor or assignee for a limited period of time in exchange for detailed public disclosure of an invention. An invention is a solution to a specific technological problem and is a product or a process. Patents are a form of intellectual property.
In this slide contains Introductionnof Indian pharmacopeia, ayurvedic, unani pharmacopeia and monographs of herbal drugs.
Presented by: P.SUDHEER KUMAR (Department of pharmaceutical analysis ).RIPER, anantapur
In this slide contains Monographs of Herbal Drugs Study in British Herbal Pharmacopoeia and American Herbal Pharmacopoeia.
Presented by: M.SUDHEESHNA (Department of pharmaceutical analysis ).RIPER, anantapur
Adulteration is the debasement of Genuine materials3.
It may be deliberated or accidentally done.
In crude drugs, this practice includes the substitution of the original crude drug, fully or partially with sub-stranded substances.
Sub-stranded substances include- Inferiority and spoilage.
Inferiority- Natural sub-stranded condition whose natural constituent is below the minimum standard.
Spoilage- sub-stranded condition produced by microbial or pest infestation.
Herbal drugs are usually considered safe but when taken along with other drugs of chemical origin (allopathic drugs), they do interact with them and cause Bio-drug interaction
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
INDIAN AND INTERNATIONAL PATENT LAW AS APPLICABLE TO HERBAL AND NATURAL PRODUCTSTejaswini Chandra
ITS A USEFUL TOPIS FOR LAW STUDNETS REGARDING THE HERBAL DRUGS AND NATURAL PRODUCTS .
ALSO USEFUL FOR THE MPHARM STUDENTS OF ALL DOMAIN TO STUDY REGARDING THE PATENT LAW
HOPE YOU ALL MAKE USE OF IT TO FULLEST AND SUCCEED.
As we all know chromatographic fingerprinting of botanicals is a quite recent concept. This presentation will help to the beginners to understand basic thories and fundamantals of thin layer chomatography. The presentation will also provide basic experiemental understanding to perfrom HPTLC fingerprinting of samples/extracts/formulations.
Herbal remedies are plants used as medicine.
People use herbal remedies to help prevent or cure disease.
They use them to get relief from symptoms, boost energy, relax, or lose weight.
Herbal remedies are a type of dietary supplement. They are not medicines.
Herbals are not regulated like medicines.
Herbals do not need to be rigidly tested before they are sold.
Herbals may not work as claimed.
Labels do not need to be approved.
It may not list the correct amount of an ingredient.
Stability testing of natural products.docxKipaPape
Stability is defined as the capacity of drug to remain within established specification limits to maintain its identity, strength, quality and purity throughout the retest or expiration dating period.
It is the ability of formulations to retain its physical, chemical, microbiological and toxicological parameters same that time of manufacturer.
Global Market For Herbal Products In IndiaANKITA MANKAR
Medicinal plants, also called medicinal herbs, have been discovered and used in traditional medicine practices since prehistoric times. Plants synthesise hundreds of chemical compounds for functions including defence against insects, fungi, diseases, and herbivorous mammals. Numerous phytochemicals with potential or established biological activity have been identified. However, since a single plant contains widely diverse phytochemicals, the effects of using a whole plant as medicine are uncertain. Further, the phytochemical content and pharmacological actions, if any, of many plants having medicinal potential remain unassessed by rigorous scientific research to define efficacy and safety.
in this slides contains method for Herbal Product Standardization and chromatographic technique.
Presented By: G.Aravind Kumar (department of industrial pharmacy).
RIPER, anantapur.
Herbal drugs are usually considered safe but when taken along with other drugs of chemical origin (allopathic drugs), they do interact with them and cause Bio-drug interaction
What is Efficacy
Why Efficacy is required for Herbal products
How Efficacy of Herbal products ensured
What are the various avenues of determining efficacy
INDIAN AND INTERNATIONAL PATENT LAW AS APPLICABLE TO HERBAL AND NATURAL PRODUCTSTejaswini Chandra
ITS A USEFUL TOPIS FOR LAW STUDNETS REGARDING THE HERBAL DRUGS AND NATURAL PRODUCTS .
ALSO USEFUL FOR THE MPHARM STUDENTS OF ALL DOMAIN TO STUDY REGARDING THE PATENT LAW
HOPE YOU ALL MAKE USE OF IT TO FULLEST AND SUCCEED.
As we all know chromatographic fingerprinting of botanicals is a quite recent concept. This presentation will help to the beginners to understand basic thories and fundamantals of thin layer chomatography. The presentation will also provide basic experiemental understanding to perfrom HPTLC fingerprinting of samples/extracts/formulations.
Herbal remedies are plants used as medicine.
People use herbal remedies to help prevent or cure disease.
They use them to get relief from symptoms, boost energy, relax, or lose weight.
Herbal remedies are a type of dietary supplement. They are not medicines.
Herbals are not regulated like medicines.
Herbals do not need to be rigidly tested before they are sold.
Herbals may not work as claimed.
Labels do not need to be approved.
It may not list the correct amount of an ingredient.
Stability testing of natural products.docxKipaPape
Stability is defined as the capacity of drug to remain within established specification limits to maintain its identity, strength, quality and purity throughout the retest or expiration dating period.
It is the ability of formulations to retain its physical, chemical, microbiological and toxicological parameters same that time of manufacturer.
Global Market For Herbal Products In IndiaANKITA MANKAR
Medicinal plants, also called medicinal herbs, have been discovered and used in traditional medicine practices since prehistoric times. Plants synthesise hundreds of chemical compounds for functions including defence against insects, fungi, diseases, and herbivorous mammals. Numerous phytochemicals with potential or established biological activity have been identified. However, since a single plant contains widely diverse phytochemicals, the effects of using a whole plant as medicine are uncertain. Further, the phytochemical content and pharmacological actions, if any, of many plants having medicinal potential remain unassessed by rigorous scientific research to define efficacy and safety.
in this slides contains method for Herbal Product Standardization and chromatographic technique.
Presented By: G.Aravind Kumar (department of industrial pharmacy).
RIPER, anantapur.
In this slides contains deep introduction about pesticides and analysis of pesticide residue in vegetables.
Presented by: M. Malarvannan (Department of pharmaceutical analysis),
RIPER, anantapur.
Introduction to General Anaesthetics
Introduction General Anaesthetics, Stages of anaesthesia, Classification of General Anaesthetics, Mechanism of action of General Anaesthetics, Pharmacokinetics, Pharmacodynamics, Uses, Side effects
Presented by
I. Sai Reddemma
Department of Pharmacology
In this slide contains pesticide used in grains, limits as per FSSAI , general detection method for pesticide in Grains and extraction procedures.
Presented by: P.Pavan Kalyan. (Department of pharmaceutical analysis).
RIPER, anantapur.
In this slide contains principle, advantage, dis advantage and application of UPLC.
Presented by: P. Sudheer Kumar. (Department of pharmaceutical analysis)
RIPER, anantapur.
Introduction to Pharmacology of Anti-depressants
Classification, Ideal characteristics, Mechanism of action, Pharmacokinetic profile, Indications, Adverse effects, Drug interactions, Contra indications, Current trends, Conclusion
Presented by
G. Sai Swetha
Department of Pharmacology
In this slide contains introduction, principle, precautions, solution and assay method for vitamin B series.
Presented by: P. VENKATESH (Department of pharmaceutical analysis),
RIPER, anantapur
In this slide contains the deep explanation of Methods of Determination for Drug-Excipient Compatibility Studies.
Presented by: G.Aravind Kumar (Department of industrial pharmacy),
RIPER, anantapur.
Introduction to Histamine and Antihistamine
Role of histamine, Synthesis, Storage, release of histamine
Mechanism of action of histamine
Anti histamine, Therapeutic uses, Adverse effects
Presented by
Shaik Sabeena
Department of Pharmacology
In this slide contains introduction about pesticide, steps involved in pesticide analysis and different methods for estimation of pesticide residue in milk.
Presented by: G.Hima Bindu (Deparment of pharmaceutical analysis),
RIPER,anantapur.
Introduction to Sedative-Hypnotics Drugs
Sleep, Introduction to Sedatives -hypnotics, Sedative-hypnotic drug classification, Pharmacology of sedative-hypnotic drugs, Overview, New inventions
Presented by
AGGIM SUMASHREE
Department of Pharmacology
Introduction to Opioid analgesis, Terms, History, Classification, Morphine, Opioid receptors, Mechanism of action, Pharmacological actions of morphine, Pharmacokinetics, Adverse effects, Contraindications, Therapeutic uses
Presented by
B . Kranthi Kumar
Department of Pharmacology
Introduction to Screening Models Of Anti Cancer Drugs
Need for novel anti cancer drugs, In - vitro methods, In - vivo methods, Advantages and disadvantages
Presented by
T. Niranjan Reddy
Department of Pharmacology
JOURNAL CLUB PRESENTATION (20L81S0402-PA & QA)
Presented by: K VENKATSAI PRASAD (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Monographs of herbal drugs: Siddha and Unani pharmacopeia
1. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 1
A Seminar as a part of curricular requirement
for I year M. Pharm II semister.
Presented by
Mr.P.Venkatesh.
(Reg. No. 20L81S0714)
Department of Pharmaceutical Analysis.
MONOGRAPHS OF HERBAL DRUGS:
SIDDHA AND UNANI PHARMACOPIA
2. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 2
• Unani pharmacopoeia of India
• Monograph format for UPI
• UPI monograph
• Siddha pharmacopoeia of India
• Monograph format for SPI
• SPI monograph
• Reference
3. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 3
• The unani system of medicine offers treatment of disease related to all
the system and organs of the human body.
• Treatment for chronic ailment and diseases for skin, liver, musculoskeletal
and reproductive systems immunological disorder.
• The unani system of medicine has a long and impressive record in India.
• It was introduced on India by the Arabs and Persian during eighth
century.
• Unani pharmacopoeia committee (UPC) was initially established in march
1994 under the chairmanship of col. Sir ramnath chopra.
Unani pharmacopoeia of India
4. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 4
Unani pharmacopoeia of India
• Unani medicine originated in Greece and is primarily based on the
principles pronounced by ancient Greek practitioner's Hippocrates
and Galen.
• Although siddha is very common in south India and Ayurveda is
equally common where unani which is holistic medicine is quote
common through out India.
• Buqrat ( better known as Hippocrates) recognized as father of unani
medicine.
• Unani medicine system was introduced to India about a thousand
years ago by the Muslims and became indigenous to the country.
• It is now practiced in the in do Pakistan sub continent.
5. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 5
• Development of publication of unani pharmacopoeia of India.
Unani pharmacopoeia of India
Publication of aurvedic
pharmacopoeia
No of drugs
Unani pharmacopoeia of India
volume I
45
Unani pharmacopoeia of India
volume II
50
Unani pharmacopoeia of India
volume III
53
Unani pharmacopoeia of India
volume IV
50
Unani pharmacopoeia of India
volume V
52
6. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 6
Monograph format for UPI
7. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 7
Continuation..........
• Therapeutic use:-mentioned in Arab and English.
Eg-zof-E-alam(general weakness)
• Dose:- given in gm or ml.
8. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 8
HABB-E-MUDIR
• It is a solid preparation made with the ingredients in the formulation
composition given below.
Formulation composition
1. Sibr- Aloe barbadenies mill-dried juice 2g
2. Hira kasis ferrous sulphate- crystal 1g
3. Zafran crocus sativus linn-style and stigma 1g
Method of preparation
Take all ingredients of pharmaceutical quality.
Prepare fine past of zafran
Unani monograph
9. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 9
Continuation ..........
10. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 10
Continuation ..........
Total ash NMT 16%
Acid insoluble ash NMT 13%
Alcohol soluble matter NMT 29%
PH of 1% aqueous solution 5.5 to 6.5
Disintegrating time in min NMT 30min
Loss on drying at 105°c NMT 8 %
11. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 11
• Storage in cool place in tightly closed container, protected from light and
moisture.
Action:-mudirr-e-Hariz (emmenogogue)
Therapeutic use:-Ehtebas-e- Tams(Amenorrhoea)
Dose:-2-4 grams.
Continuation ..........
12. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 12
Siddha pharmacopoeia of India
13. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 13
• Monograph title:-The name given on the top of the each monograph in Tamil.
• Introduction:-botanical name and part used with geographical source
• Synonyms:-synonyms in other Indian regional languages.
• Description:-microscopy and macroscopy powder characteristics.
• Assay:-TLC, HPLC and HPTLC analysis.
• Constituents:-important constituents are mentioned.
• Properties and action:- mentioned in Tamil.
• Important formulation:-mentioned in siddha class.
• Therapeutic use
• Dose :- mentioned in gm or ml
monograph format for SPI
14. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 14
Siddha monograph
AMUKKARU
• It is the dried root of withania somnifera.
Family- solanaceae
• It is a perennial shrub, found in waste land, cultivated field and open ground
throughout India
• It is also cultivated in certain areas of Madhya Pradesh and Rajasthan.
• Roots are collected in winter, washed and cut into small pieces.
• The dried roots is subjected to purification process before use.
Synonyms:-
Tamil: Amukkara
Assamese: Ashvagandha
Bengali: Ashvagandha
Gujarati: Asgandha
15. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 15
Description:-
Macroscopic
• Roots are straight , unbranched, thickness varying with age, roots bear
fiber like secondary roots.
• Outer surface buff to grey yellow with longitudinal wrinkles.
• Uneven order characteristics.
• Taste bitter and acrid.
Microscopic
• Transverse section of root show cork exfoliated or clustered, when
present rectangular, radially flattened and non signified.
• phloem consist of seven tubes companion cells, phloem parenchyma
Continuation
16. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 16
Continuation………
Foreign matter NMT 2%
Total ash NMT 2%
Acid insoluble ash NMT 1%
Alcohol soluble ash NMT 15%
Water soluble ash NMT 27%
17. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 17
Contuanition……..
18. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 18
Continuation ..........
19. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 19
1. The unani pharmacopoeia of India, first edition. Pharmacopoeia commission for
Indian medicine and homoeopathy, Ghaziabag; vol-3 part-2: page no-vii-xii,35-36.
2.Yes siddha pharmacopoeia of India, first edition. Government of India Ministry of
health and family welfare, New Delhi;2011 vol-I part-I.
Reference
20. RIPER
AUTONOMOUS
NAAC &
NBA (UG)
SIRO- DSIR
Raghavendra Institute of Pharmaceutical Education and Research - Autonomous
K.R.Palli Cross, Chiyyedu, Anantapuramu, A. P- 515721 20